FLYNN DANIEL L has a total of 34 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ASTRAEA THERAPEUTICS LLC, MEDIFRON DBT INC and BIFTU TESFAYE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 29 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | China | 1 | |
#4 | Hong Kong | 1 | |
#5 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Computer technology | |
#6 | Measurement | |
#7 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Unspecified technologies | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Bioinformatics | |
#8 | Preservation of human bodies | |
#9 | Peptides | |
#10 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Flynn Daniel L | 34 |
#2 | Petillo Peter A | 25 |
#3 | Kaufman Michael D | 19 |
#4 | Patt William C | 3 |
#5 | Rudoltz Marc S | 1 |
#6 | Smith Bryan | 1 |
Publication | Filing date | Title |
---|---|---|
US8461179B1 | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
US2012225057A1 | Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases | |
US2011189167A1 | Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases | |
US2008114006A1 | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
US2008248548A1 | Modulation of protein functionalities | |
US2008248487A1 | Modulation of protein functionalities | |
US2007078121A1 | Enzyme modulators and treatments | |
US2008045706A1 | Anti-inflammatory medicaments | |
US2008220497A1 | Modulation of protein functionalities | |
US2007191336A1 | Anti-inflammatory medicaments | |
US2004171075A1 | Modulation of protein functionalities |